Pooled-DNA sequencing identifies novel causative variants in PSEN1, GRN and MAPT in a clinical early-onset and familial Alzheimer's disease Ibero-American cohort

Topic: Brain proteins, microglia and lab models

Introduction Some familial Alzheimer's disease (AD) cases are caused by rare and highly-penetrant mutations in APP, PSEN1, and PSEN2. Mutations in GRN and MAPT, two genes associated with frontotemporal dementia (FTD), have been found in clinically diagnosed AD cases. Due to the dramatic developments in next-generation sequencing (NGS), high-throughput sequencing of targeted genomic regions of the human genome in many individuals in a single run is now cheap and feasible. Recent findings favor the rare variant-common disease hypothesis by which the combination effects of rare variants could explain a large proportion of the heritability. We utilized NGS to identify rare and pathogenic variants in APP, PSEN1, PSEN2, GRN, and MAPT in an Ibero-American cohort. Methods We performed pooled-DNA sequencing of each exon and flanking sequences in APP, PSEN1, PSEN2, MAPT and GRN in 167 clinical and 5 autopsy-confirmed AD cases (15 familial early-onset, 136 sporadic early-onset and 16 familial late-onset) from Spain and Uruguay using NGS. Follow-up genotyping was used to validate variants. After genotyping additional controls, we performed segregation and functional analyses to determine the pathogenicity of validated variants. Results We identified a novel G to T transition (g.38816G>T) in exon 6 of PSEN1 in a sporadic early-onset AD case, resulting in a previously described pathogenic p.L173F mutation. A pathogenic p.L392V mutation in exon 11 was found in one familial early-onset AD case. We also identified a novel CC insertion (g.10974_10975insCC) in exon 8 of GRN, which introduced a premature stop codon, resulting in nonsense-mediated mRNA decay. This GRN mutation was associated with lower GRN plasma levels, as previously reported for other GRN pathogenic mutations. We found two variants in MAPT (p.A152T, p.S318L) present only in three AD cases but not controls, suggesting that these variants could be risk factors for the disease. Conclusions We found pathogenic mutations in PSEN1, GRN and MAPT in 2.33% of the screened cases. This study suggests that pathogenic mutations or risk variants in MAPT and in GRN are as frequent in clinical AD cases as mutations in APP, PSEN1 and PSEN2, highlighting that pleiotropy of MAPT or GRN mutations can influence both FTD and AD phenotypic traits.

@article{jin2012-22906081,
  author  = {Jin, S. C. and Pastor, P. and Cooper, B. and Cervantes, S. and Benitez, B. A. and Razquin, C. and Goate, A. and {Ibero-American Alzheimer Disease Genetics Group Researchers} and others},
  title   = {{Pooled-DNA sequencing identifies novel causative variants in PSEN1, GRN and MAPT in a clinical early-onset and familial Alzheimer's disease Ibero-American cohort}},
  journal = {Alzheimer's research \& therapy},
  year    = {2012},
  doi     = {10.1186/alzrt137},
  pmid    = {22906081},
  url     = {https://doi.org/10.1186/alzrt137}
}

Key findings

• Mutations in GRN and MAPT, two genes associated with frontotemporal dementia (FTD), have been found in clinically diagnosed AD cases.
• Results We identified a novel G to T transition (g.38816G>T) in exon 6 of PSEN1 in a sporadic early-onset AD case, resulting in a previously described pathogenic p.L173F mutation.
• This GRN mutation was associated with lower GRN plasma levels, as previously reported for other GRN pathogenic mutations.
• We found two variants in MAPT (p.A152T, p.S318L) present only in three AD cases but not controls, suggesting that these variants could be risk factors for the disease.
• Conclusions We found pathogenic mutations in PSEN1, GRN and MAPT in 2.33% of the screened cases.

New to this subject? Start with our plain-English guide: Genetics →

Study details

• Effect size2.33%
• Evidence strengthModerate

Read the original

• DOI: 10.1186/alzrt137
• PubMed: 22906081
• Original source →

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

Related studies in Genetics

• African American exome sequencing identifies potential risk variants at Alzheimer disease loci Neurology. Genetics · 2017-04-07 · usefulness score 52/100
• Clinical impact of whole-genome sequencing in patients with early-onset dementia Journal of neurology, neurosurgery, and psychiatry · 2022-07-29 · usefulness score 52/100
• Whole exome sequencing study identifies novel rare and common Alzheimer's-Associated variants involved in immune response and transcriptional regulation Molecular psychiatry · 2018-08-14 · usefulness score 45/100
• Local genetic covariance analysis with lipid traits identifies novel loci for early-onset Alzheimer’s Disease PLoS Genetics · 2025-03-17 · usefulness score 65/100
• Differential Aging Analysis in Human Cerebral Cortex Identifies Variants in TMEM106B and GRN that Regulate Aging Phenotypes Cell systems · 2017-03-18 · usefulness score 38/100
• Searching for responders to multidomain dementia prevention in late life: A pooled analysis of individual participant data from the MAPT and preDIVA trials Alzheimer s & Dementia · 2025-01-17 · usefulness score 45/100

Also tagged “grn”

3 studies in the library carry the topic tag “grn”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 3 tagged studies.

• Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study The Lancet. Neurology · 2018-04-30 · usefulness score 78/100 · Genetics

Similar studies

• The PSEN1 I143T mutation in a Swedish family with Alzheimer's disease: clinical report and quantification of Aβ in different brain regions 2010 · Biomarkers
• A genome-wide association study for late-onset Alzheimer's disease using DNA pooling 2008 · Genetics
• A Novel PSEN1 M139L Mutation Found in a Chinese Pedigree with Early-Onset Alzheimer's Disease Increases Aβ42/Aβ40 ratio 2019 · Biomarkers
• Whole-genome sequencing suggests a chemokine gene cluster that modifies age at onset in familial Alzheimer's disease 2015 · Genetics
• Whole-exome sequencing in 20,197 persons for rare variants in Alzheimer's disease 2018 · Genetics
• Whole-genome sequencing reveals new Alzheimer's disease-associated rare variants in loci related to synaptic function and neuronal development 2021 · Risk factors

More on Genetics

• A review that covers this ground APOE Variants in an Iberian Alzheimer Cohort Detected through an Optimized Sanger Sequencing Protocol Genes · 2020-12-22 · usefulness score 73/100
• Newest in this subject APH-1A and CDK5 Expression Correlates with Tau Hyperphosphorylation and Its Attenuation by Brahmi and Donep-M in STZ induced Alzheimer’s Disease Model Research Square · 2026-10-31 · Preprint — not yet peer-reviewed · usefulness score 16/100
• Newest in this subject Integrative systems biology identifies shared neuroimmune co-expression programmes across pulmonary tuberculosis and Alzheimer's disease Research Square · 2026-10-30 · Preprint — not yet peer-reviewed · usefulness score 16/100

See all studies in Genetics →